Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.
about
Comparison of ceftazidime with cefamandole for therapy of community-acquired pneumoniaUse of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms.Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus.Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae.Toxic and adverse reactions encountered with new beta-lactam antibiotics.Respiratory superinfections after the use of third-generation cephem antibiotics.
P2860
Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.
description
1982 nî lūn-bûn
@nan
1982 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.
@ast
Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.
@en
type
label
Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.
@ast
Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.
@en
prefLabel
Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.
@ast
Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.
@en
P2860
P356
P1476
Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.
@en
P2093
Schleupner CJ
P2860
P304
P356
10.1128/AAC.21.2.327
P407
P577
1982-02-01T00:00:00Z